UY26372A1 - "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " - Google Patents
"imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "Info
- Publication number
- UY26372A1 UY26372A1 UY26372A UY26372A UY26372A1 UY 26372 A1 UY26372 A1 UY 26372A1 UY 26372 A UY26372 A UY 26372A UY 26372 A UY26372 A UY 26372A UY 26372 A1 UY26372 A1 UY 26372A1
- Authority
- UY
- Uruguay
- Prior art keywords
- preparation
- imidazo
- bicíclicas
- aminas
- drugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Abstract
Imidazo-3-il-aminas bicíclicas de la fórmula generamente aceptables, procedimiento para su preparación y medicamentos que contienen como sustancia activa al menos un imidazo-3- il-amina bicíclica de la fórmula general I en forma de su base o una sal farmacéuticamente aceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19948434A DE19948434A1 (de) | 1999-10-08 | 1999-10-08 | Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine |
DE1999148438 DE19948438B4 (de) | 1999-10-08 | 1999-10-08 | Bicyclische Imidazo-3-aminderivate |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26372A1 true UY26372A1 (es) | 2000-12-29 |
Family
ID=26055218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26372A UY26372A1 (es) | 1999-10-08 | 2000-10-05 | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " |
Country Status (26)
Country | Link |
---|---|
US (1) | US6638933B2 (es) |
EP (1) | EP1218382B1 (es) |
JP (1) | JP2003511451A (es) |
KR (1) | KR100756592B1 (es) |
CN (1) | CN1257169C (es) |
AR (1) | AR025962A1 (es) |
AT (1) | ATE258554T1 (es) |
AU (1) | AU779197B2 (es) |
BR (1) | BR0014818A (es) |
CA (1) | CA2382919C (es) |
CO (1) | CO5251378A1 (es) |
CZ (1) | CZ20021210A3 (es) |
DE (1) | DE50005155D1 (es) |
DK (1) | DK1218382T3 (es) |
ES (1) | ES2213611T3 (es) |
HK (1) | HK1047747B (es) |
HU (1) | HUP0203052A3 (es) |
NO (1) | NO322754B1 (es) |
NZ (2) | NZ518390A (es) |
PE (1) | PE20010634A1 (es) |
PL (1) | PL355206A1 (es) |
PT (1) | PT1218382E (es) |
RU (1) | RU2264402C2 (es) |
SK (1) | SK286788B6 (es) |
UY (1) | UY26372A1 (es) |
WO (1) | WO2001027111A2 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040077605A1 (en) * | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
DE10043845A1 (de) * | 2000-09-06 | 2002-03-14 | Gruenenthal Gmbh | Verfahren zur Messung der Aktivität der NO-Synthase |
EP1854798A3 (en) | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
EP1343785A2 (de) * | 2000-12-13 | 2003-09-17 | Basf Aktiengesellschaft | Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel |
US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
DE102004021716A1 (de) * | 2004-04-30 | 2005-12-01 | Grünenthal GmbH | Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen |
EP1765351B9 (en) * | 2004-06-09 | 2010-03-24 | Oncalis AG | Protein kinase inhibitors |
US7923041B2 (en) * | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
CA2602444C (en) * | 2005-03-23 | 2013-03-19 | F.Hoffmann-La Roche Ag | Acetylenyl-pyrazolo-pyrimidine derivatives as mglur2 antagonists |
CN101263142A (zh) * | 2005-05-20 | 2008-09-10 | 阿雷生物药品公司 | Raf抑制剂化合物及其使用方法 |
EP1901748B1 (en) * | 2005-06-09 | 2010-09-08 | Oncalis AG | Angiogenesis inhibitors |
WO2007028051A2 (en) | 2005-09-02 | 2007-03-08 | Abbott Laboratories | Novel imidazo based heterocycles |
EP1845098A1 (en) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands |
BRPI0712531A2 (pt) * | 2006-05-31 | 2012-12-25 | Galapagos Nv | composto de triazolopirazina éteis para o tratamento de doenÇas degenarativas e inflamatàrias |
US20100173930A1 (en) * | 2006-08-01 | 2010-07-08 | Alex Muci | Certain Chemical Entities, Compositions and Methods |
US8227603B2 (en) * | 2006-08-01 | 2012-07-24 | Cytokinetics, Inc. | Modulating skeletal muscle |
US8299248B2 (en) * | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
PL2583970T3 (pl) * | 2006-08-02 | 2016-05-31 | Cytokinetics Inc | Określone cząstki chemiczne, kompozycje i sposoby zawierające imidazopirymidyny |
EP1974729A1 (en) * | 2007-03-28 | 2008-10-01 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists |
US7851484B2 (en) * | 2007-03-30 | 2010-12-14 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
GB0708188D0 (en) * | 2007-04-27 | 2007-06-06 | Merck Sharp & Dohme | Therapeutic compounds |
JP4654325B2 (ja) * | 2008-04-15 | 2011-03-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 3−フェニルピラゾロ[5,1−b]チアゾール化合物 |
US20110178106A1 (en) * | 2008-07-10 | 2011-07-21 | Southern Research Institute Office Of Commercializ | 5-quinolinone and imidazopyridine compounds and use thereof |
CN102216298B (zh) * | 2008-09-16 | 2014-04-16 | Csir公司 | 作为hiv-1逆转录酶抑制剂的咪唑并吡啶和咪唑并嘧啶 |
SG10201503671TA (en) | 2008-12-05 | 2015-06-29 | Takeda Vaccines Inc | Compositions, methods and uses for inducing viral growth |
AR078521A1 (es) * | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
SG10201605707UA (en) | 2011-07-13 | 2016-09-29 | Cytokinetics Inc | Combination als therapy |
WO2014076021A1 (en) * | 2012-11-14 | 2014-05-22 | F. Hoffmann-La Roche Ag | Imidazopyridine derivatives |
BR112015020998B1 (pt) * | 2013-03-14 | 2022-10-18 | Galapagos Nv | Compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios |
WO2017160922A1 (en) | 2016-03-16 | 2017-09-21 | Kalyra Pharmaceuticals, Inc. | Analgesic compounds |
US11731967B2 (en) | 2017-04-28 | 2023-08-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of TRIM33 and methods of use |
WO2019070943A1 (en) * | 2017-10-04 | 2019-04-11 | Dana-Farber Cancer Institute, Inc. | SMALL MOLECULE INHIBITION OF SALL4 TRANSCRIPTION FACTOR AND USES THEREOF |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0068378B1 (en) | 1981-06-26 | 1986-03-05 | Schering Corporation | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
NZ221996A (en) * | 1986-10-07 | 1989-08-29 | Yamanouchi Pharma Co Ltd | Imidazo-pyridine derivatives and pharmaceutical compositions |
TW274551B (es) * | 1991-04-16 | 1996-04-21 | Takeda Pharm Industry Co Ltd | |
DE4327027A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
CA2218705A1 (en) * | 1995-04-21 | 1996-10-24 | Shinnippon Pharmaceutical Inc. | Fused imidazo¬1,2-a|pyridines |
WO2002002557A2 (en) * | 2000-06-30 | 2002-01-10 | Neurogen Corporation | 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands |
-
2000
- 2000-09-18 BR BR0014818-0A patent/BR0014818A/pt not_active Application Discontinuation
- 2000-09-18 ES ES00967692T patent/ES2213611T3/es not_active Expired - Lifetime
- 2000-09-18 KR KR1020027004516A patent/KR100756592B1/ko not_active IP Right Cessation
- 2000-09-18 RU RU2002110102/04A patent/RU2264402C2/ru not_active IP Right Cessation
- 2000-09-18 SK SK436-2002A patent/SK286788B6/sk not_active IP Right Cessation
- 2000-09-18 AU AU77771/00A patent/AU779197B2/en not_active Ceased
- 2000-09-18 EP EP00967692A patent/EP1218382B1/de not_active Expired - Lifetime
- 2000-09-18 CZ CZ20021210A patent/CZ20021210A3/cs unknown
- 2000-09-18 PT PT00967692T patent/PT1218382E/pt unknown
- 2000-09-18 DE DE50005155T patent/DE50005155D1/de not_active Expired - Lifetime
- 2000-09-18 WO PCT/EP2000/009096 patent/WO2001027111A2/de active IP Right Grant
- 2000-09-18 CA CA002382919A patent/CA2382919C/en not_active Expired - Fee Related
- 2000-09-18 PL PL00355206A patent/PL355206A1/xx not_active IP Right Cessation
- 2000-09-18 NZ NZ518390A patent/NZ518390A/en unknown
- 2000-09-18 DK DK00967692T patent/DK1218382T3/da active
- 2000-09-18 AT AT00967692T patent/ATE258554T1/de active
- 2000-09-18 HU HU0203052A patent/HUP0203052A3/hu unknown
- 2000-09-18 NZ NZ518439A patent/NZ518439A/en unknown
- 2000-09-18 JP JP2001530329A patent/JP2003511451A/ja not_active Withdrawn
- 2000-09-18 CN CNB008159866A patent/CN1257169C/zh not_active Expired - Fee Related
- 2000-10-05 CO CO00075814A patent/CO5251378A1/es not_active Application Discontinuation
- 2000-10-05 UY UY26372A patent/UY26372A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105254A patent/AR025962A1/es unknown
- 2000-10-06 PE PE2000001064A patent/PE20010634A1/es not_active Application Discontinuation
-
2002
- 2002-04-03 NO NO20021565A patent/NO322754B1/no not_active IP Right Cessation
- 2002-04-08 US US10/117,333 patent/US6638933B2/en not_active Expired - Fee Related
- 2002-12-28 HK HK02109382.5A patent/HK1047747B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
AR023972A1 (es) | Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos | |
ATE309798T1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
ES2061799T3 (es) | Nuevo preparado medicamentoso y procedimiento para su preparacion. | |
AR029175A1 (es) | Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento | |
AR028504A2 (es) | Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial | |
HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
UY26371A1 (es) | Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen | |
ES2045182T3 (es) | Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen. | |
ATE287264T1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
DE60102590T2 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
AR021086A1 (es) | Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento. | |
ES2062137T3 (es) | Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea. | |
ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
EE9400296A (et) | Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid | |
DE69813263T2 (de) | Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte | |
ITMI922742A0 (it) | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
CO4930262A1 (es) | Producto farmaceutico cristalino, su preparacion y uso como sustancia terapeutica | |
ATE234096T1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
HUP0103623A3 (en) | Bispiperidines as antithrombotic agents, their process for preparation and medicament containing them as active ingredient | |
ATE314851T1 (de) | Synergistische wechselwirkung von abacavir und alovudin | |
ES2146683T3 (es) | Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos. | |
ECSP003693A (es) | Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen | |
AR003117A1 (es) | El uso de derivado de aminotetralina para la preparacion de composiciones farmaceuticas para la terapia de enfermedades cardiovasculares y dichascomposiciones farmaceuticas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20130111 |